Valneva SE Granted Conditional Marketing Authorization for its COVID-19 Vaccine Candidate
Valneva SE (Nasdaq: VALN) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom has granted Conditional Marketing Authorization (CMA) for its inactivated whole-virus COVID-19 vaccine candidate, VLA2001. Shares up 8% Shares of Valneva SE...